BioAge Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	241.78	188.89	354.35	24.96	27.64
Short-Term Investments	141.42	92.21	-	-	-
Cash & Short-Term Investments	383.19	281.1	354.35	24.96	27.64
Cash Growth	19.55%	-20.67%	1319.84%	-9.72%	-
Accounts Receivable	0.71	0.77	-	-	-
Other Current Assets	7.96	4.93	2.75	0.35	0.39
Total Current Assets	391.86	286.79	357.1	25.31	28.03
Net Property, Plant & Equipment	3.8	3.75	0.79	0.52	0.37
Long-Term Investments	1.78	4.13	0.1	0.1	-
Other Long-Term Assets	0.22	0.22	0.24	-	0.03
Total Assets	397.65	294.89	358.23	25.92	28.43
Accounts Payable	3.07	2.67	2	1.87	2.26
Accrued Expenses	4.77	8.48	11.75	7.94	3.38
Short-Term Debt	-	-	-	20.67	-
Current Portion of Long-Term Debt	1.16	2.65	6	6	0.17
Current Portion of Leases	0.65	0.58	0.2	0.19	0.05
Unearned Revenue	6.19	5.75	7.83	3.31	-
Other Current Liabilities	-	-	-	18.18	-
Total Current Liabilities	15.83	20.14	27.78	58.17	5.86
Long-Term Debt	-	-	2.5	8.2	2.25
Long-Term Leases	2.23	2.33	-	-	-
Other Long-Term Liabilities	0.48	0.37	4.83	0.23	0.15
Total Long-Term Liabilities	2.71	2.7	7.33	8.43	2.41
Total Liabilities	18.53	22.84	35.11	66.6	8.27
Additional Paid-in Capital	734.72	605.19	575.69	8.14	5.12
Accumulated Other Comprehensive Income	0.07	0.28	0.25	0.16	0.17
Retained Earnings	-355.67	-333.42	-252.81	-181.7	-117.85
Total Common Shareholders' Equity	379.12	272.05	323.13	-173.4	-112.56
Minority Interest	-	-	-	132.72	132.72
Shareholders' Equity	379.12	272.05	323.13	-40.67	20.16
Total Liabilities & Equity	397.65	294.89	358.23	25.92	28.43
Total Debt	4.03	5.56	8.7	35.07	2.47
Net Cash (Debt)	379.16	275.54	345.65	-10.11	25.18
Net Cash Growth	37.61%	-20.28%	-	-	-
Net Cash Per Share	10.09	7.67	32.22	-6.04	15.06
Book Value	379.12	272.05	323.13	-173.4	-112.56
Book Value Per Share	10.09	7.57	30.12	-103.66	-67.33
Tangible Book Value	379.12	272.05	323.13	-173.4	-112.56
Tangible Book Value Per Share	10.09	7.57	30.12	-103.66	-67.33

SEC Filings: 10-K · 10-Q